말 건강관리 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 질환별, 활동별, 유통 채널별, 지역별 및 경쟁(2021-2031년)

The Global Equine Healthcare Market is anticipated to expand from USD 3.69 billion in 2025 to USD 5.96 billion by 2031, demonstrating an 8.32% Compound Annual Growth Rate. This specialized segment of veterinary medicine focuses on developing and delivering pharmaceuticals, biologics, diagnostics, and medical devices specifically for the prevention and treatment of diseases and injuries in horses. Market growth is primarily fueled by the increasing economic value associated with competitive equestrian sports, which necessitates rigorous physical maintenance for high-performance animals, alongside a growing global dedication to animal welfare standards that encourages investment in preventative medical care.

However, the industry faces notable impediments, including escalating operational costs and a scarcity of skilled professionals. A 2025 report by American Horse Publications indicated that 50.3 percent of equine owners and managers considered the rising cost of horsekeeping as the most pressing industry issue, with an additional 35.5 percent reporting challenges in accessing veterinary services. These financial burdens and the shortage of qualified practitioners significantly hinder market expansion by restricting the affordability and availability of essential medical interventions for horse owners.

Market Driver

The primary driver for market growth is the significant expansion of the global equestrian sports and racing industry, which inherently demands advanced veterinary care to preserve the athletic condition of competition horses. With increasing economic incentives in disciplines like show jumping, dressage, and thoroughbred racing, owners are heavily investing in extensive preventative health programs and rehabilitation services to extend the competitive careers of their valuable equine assets. Evidence for this heightened industry engagement comes from British Equestrian's June 2025 'State of the Nation 2024' report, which noted an 11.7 percent increase in federation memberships, directly correlating to a surge in demand for routine vaccinations, nutritional support, and specialized sports medicine essential for maintaining competition-ready horses.

Concurrently, breakthroughs in equine veterinary diagnostics and therapeutic technologies are transforming treatment possibilities, especially with the integration of novel biologics and regenerative medicine. This innovation signifies a notable industry shift from managing symptoms to delivering curative solutions, propelled by substantial investments in pharmaceutical research and development. For instance, Boehringer Ingelheim significantly boosted its R&D spending to EUR 6.2 billion by April 2025, emphasizing a proactive approach to developing next-generation animal health solutions. This dedication to cutting-edge innovation is positively impacting the financial performance of major market players, as illustrated by Zoetis reporting $2.4 billion in third-quarter revenue in 2024, reflecting strong commercial adoption of its diverse animal health product range.

Market Challenge

The Global Equine Healthcare Market's expansion is significantly impeded by the combined pressures of increasing operational expenses and a critical shortage of qualified professionals. This scarcity of veterinary practitioners creates a substantial supply-side bottleneck, hindering the industry's capacity to adequately address the escalating demand for specialized medical services. Veterinary practices face immense challenges in maintaining sufficient staffing, leading to unsustainable workloads for existing personnel, which in turn exacerbates attrition rates and physically restricts the volume of cases that can be managed.

This reduced availability of veterinary expertise inevitably drives up service costs and prolongs wait times for non-emergency treatments, compelling horse owners to limit their veterinary engagements. Such a dynamic directly curtails market revenue growth by capping the potential volume of efficiently delivered medical interventions. A clear indication of this workforce strain is the 2025 report from the Society of Practising Veterinary Surgeons, showing that 37 percent of veterinarians worked out-of-hours shifts weekly, a significant rise from 20 percent the prior year. This statistic underscores the intense pressure on current infrastructure, severely limiting the market's ability to scale operations in response to global demand.

Market Trends

A significant trend reshaping clinical practices is the integration of Artificial Intelligence in diagnostics, which automates image analysis and improves the accuracy of decision-making. This technological advancement directly helps mitigate the industry's critical workforce shortage by enabling practitioners to accelerate case reviews and minimize errors, thanks to machine learning algorithms capable of identifying subtle pathologies often missed by the human eye. By adopting these digital solutions, veterinary clinics can substantially enhance patient throughput and diagnostic reliability without needing a proportional increase in staffing. For example, Vetel Diagnostics reported in July 2024 that its proprietary AI software can analyze equine radiographs and identify significant morphological deviations with 99.8 percent accuracy, showcasing the power of these systems to augment veterinary expertise.

Concurrently, the widespread adoption of wearable health monitoring devices is transforming the market from a reactive treatment model to one of proactive wellness management through continuous biometric tracking. These IoT-enabled technologies, including smart halters and gait sensors, deliver real-time data on vital signs, facilitating the early detection of conditions such as colic or lameness before they progress to critical stages. This capability optimizes veterinary visits by supplying objective historical data, which is crucial for preserving the physical integrity and performance of high-value animals. The swift uptake of this technology is evident in user adoption figures, with Arioneo's EQUIMETRE Vet connected sensor platform being adopted by over 22,700 users globally by April 2024, indicating a substantial demand for data-driven equine health oversight.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim GmbH
• Merck & Co., Inc.
• Hallmarq Veterinary Imaging Ltd
• Esaote SpA
• Vetoquinol SA
• IDEXX Laboratories, Inc.
• Dechra Pharmaceuticals PLC
• Arthrex Inc.
• Heska Corporation

Report Scope

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product

• Vaccines
• Pharmaceuticals
• Medicinal Feed Additives
• Diagnostics
• Software & Services
• Others

Equine Healthcare Market, By Indication

• Musculoskeletal Disorders
• Parasite Control
• Internal Medicine
• Equine Herpes Virus
• Equine Encephalomyelitis
• Equine Influenza
• West Nile Virus
• Tetanus
• Others

Equine Healthcare Market, By Activity

• Sports/Racing
• Recreation
• Others

Equine Healthcare Market, By Distribution Channel

• Veterinary Hospitals & Clinics
• E-commerce
• Others

Equine Healthcare Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
  • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
  • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Equine Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Activity
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Activity
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Equine Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Activity
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Equine Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Activity
      • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Activity
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Activity
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Equine Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Activity
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Equine Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Activity
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Equine Healthcare Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Activity
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Equine Healthcare Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Activity
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Equine Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Activity
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Equine Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Activity
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Equine Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Activity
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Equine Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Activity
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Equine Healthcare Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Activity
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Equine Healthcare Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Activity
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Equine Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Activity
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Equine Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Activity
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Equine Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Activity
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Equine Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Activity
      • 9.3.3.2.4. By Distribution Channel

10. South America Equine Healthcare Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Activity
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Equine Healthcare Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Activity
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Equine Healthcare Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Activity
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Equine Healthcare Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Activity
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Equine Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim GmbH
• 15.3. Merck & Co., Inc.
• 15.4. Hallmarq Veterinary Imaging Ltd
• 15.5. Esaote SpA
• 15.6. Vetoquinol SA
• 15.7. IDEXX Laboratories, Inc.
• 15.8. Dechra Pharmaceuticals PLC
• 15.9. Arthrex Inc.
• 15.10. Heska Corporation

16. Strategic Recommendations

17. About Us & Disclaimer